Peoples Bancorp Full Year 2024 Earnings: In Line With Expectations

Peoples Bancorp (NASDAQ:PEBO) Full Year 2024 Results

Key Financial Results

• Revenue: US$565.4m (up 17% from FY 2023).
• Net income: US$116.2m (up 3.2% from FY 2023).
• Profit margin: 21% (down from 23% in FY 2023). The decrease in margin was driven by higher expenses.
• EPS: US$3.34.

PEBO Banking Performance Indicators

• Net interest margin (NIM): 4.21% (down from 4.55% in FY 2023).
• Cost-to-income ratio: 57.9% (up from 54.4% in FY 2023).
• Non-performing loans: 0.67% (up from 0.52% in FY 2023).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Peoples Bancorp Meets Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) was also in line with analyst expectations.

In the last 12 months, the only revenue segment was Community Banking contributing US$565.4m. Explore how PEBO's revenue and expenses shape its earnings.

Looking ahead, revenue is expected to decline by 8.7% p.a. on average during the next 2 years, while revenues in the Banks industry in the US are expected to grow by 7.2%.

Performance of the American Banks industry.

The company's shares are up 1.1% from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. See our latest analysis on Peoples Bancorp's balance sheet health.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.